Old Web
English
Sign In
Acemap
>
Paper
>
Abstract CT118: PK-Biomarker-Safety modelling aids choice of recommended Phase II dose and schedule for AZD6738 (ATR inhibitor)
Abstract CT118: PK-Biomarker-Safety modelling aids choice of recommended Phase II dose and schedule for AZD6738 (ATR inhibitor)
2018
Alienor Berges
S. Y. Amy Cheung
Andrew Pierce
Emma Dean
Brunella Felicetti
Nathan Standifer
Simon Smith
James Yates
Alan Lau
Christine Stephens
Matthew Krebs
Kevin J. Harrington
Simon J. Hollingsworth
Keywords:
Immunology
Pharmacology
Medicine
Biomarker (medicine)
Correction
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]
map